RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN IN SERUM CANNOT DISTINGUISH PATIENTS WITH PROSTATE CANCER FROM THOSE WITH CHRONIC INFLAMMATION OF THE PROSTATE
Abstract
Purpose:
We demonstrate the effect of chronic inflammation of the prostate on the ratio of free-to-total prostate specific antigen (PSA) in serum calculated as a percentage of free PSA and, therefore, that percentage of free PSA is an unspecific means to distinguish among prostate cancer, chronic prostatitis and benign prostatic hyperplasia (BPH).
Materials and Methods:
Total, free and percentage of free PSA was measured in 66 men with prostate cancer, 119 with BPH and 17 with asymptomatic chronic prostatitis. In all patients the diagnosis was histopathologically confirmed by microscopic examination of prostatic specimens after sextant biopsy, transurethral prostatic resection or prostatectomy.
Results:
The median values of total, free and percentage of free PSA were 4.11 micro g./l., 0.75 micro g./l. and 20.4% in patients with BPH, 10.0 micro g./l., 0.84 micro g./l. and 8.5% in those with prostate cancer, and 7.60 micro g./l., 1.23 micro g./l. and 10.6% in those with chronic prostatitis. Patients with prostate cancer and chronic prostatitis had a significantly lower percentage of free PSA than those with BPH. Receiver operating characteristics curve analysis showed that percentage of free PSA as a discriminator between prostate cancer and BPH was not suitable for differentiating between prostate cancer and chronic prostatitis.
Conclusions:
Chronic prostatitis is not characterized by elevated total PSA concentrations alone but also by a decreased percentage of free PSA, a tendency similar to that in prostate cancer. This unspecific change in percentage of free PSA must be considered to interpret the percentage of free PSA correctly.
References
- 1 : Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review. Prostate1996; 7: 64. Google Scholar
- 2 : Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen. Prostate1996; 7: 48. Google Scholar
- 3 : A guide to the interpretation of serum prostate specific antigen levels. Clin. Biochem.1995; 28: 221. Google Scholar
- 4 : Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate1992; 20: 105. Crossref, Medline, Google Scholar
- 5 : Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates. Cancer1991; 68: 1592. Crossref, Medline, Google Scholar
- 6 : Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. Urology1994; 43: 191. Crossref, Medline, Google Scholar
- 7 : Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J. Urol.1995; 154: 407. Link, Google Scholar
- 8 : Prostate-specific antigen and prostatitis in men under fifty. Eur. Urol.1996; 30: 24. Google Scholar
- 9 : Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis. Brit. J. Urol.1995; 76: 47. Google Scholar
- 10 : Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate1994; 25: 91. Crossref, Medline, Google Scholar
- 11 : Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J. Urol.1997; 157: 1301. Link, Google Scholar
- 12 : Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology1996; 48: 55. Google Scholar
- 13 : Determination of the “reflex range” and appropriate cutpoints for % free PSA in 413 men referred for prostate evaluation using the AxSYM SYSTEM. Urology1997; 49: 19. Google Scholar
- 14 : Analytical performance and clinical validity of two free prostate-specific antigen assays compared. Clin. Chem.1996; 42: 1026. Google Scholar
- 15 : Software for illustrative presentation of basic clinical characteristics of laboratory test-GraphROC for Windows. Scand. J. Clin. Lab. Invest.1995; 55: 43. Google Scholar
- 16 : Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer. Amer. J. Clin. Path.1994; 102: S31. Google Scholar
- 17 : Elevated serum PSA and acute bacterial prostatitis. Letter to the Editor. Urology1990; 35: 373. Google Scholar
- 18 : Serum prostate specific antigen complexed to alpha1-antichymotrypsin as an indicator of prostate cancer. J. Urol.1993; 150: 100. Abstract, Google Scholar
- 19 : Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology1994; 43: 427. Google Scholar
- 20 : Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate. Prostate1995; 27: 212. Google Scholar
- 21 : Prostate specific antigen in benign prostatic hyperplasia: purification and characterization. J. Urol.1997; 157: 2166. Link, Google Scholar
- 22 : Complex formation between PSA isoenzymes and protease inhibitors. J. Urol.1996; 155: 1099. Link, Google Scholar
From the Departments of Urology and Pathology, University Hospital Charite, Humboldt University Berlin, Berlin, Germany.
